Clinical risk factors for ascites in metastatic pancreatic cancer

BACKGROUND: Malignant ascites is common in metastatic pancreatic cancer (mPC) and its management still remains a clinical challenge. Early identification of patients at risk for ascites development may support and guide treatment decisions. MATERIALS AND METHODS: Data of patients treated for mPC at...

Descripción completa

Detalles Bibliográficos
Autores principales: Berger, J.M., Alany, A., Puhr, R., Berchtold, L., Friedrich, A., Scheiner, B., Prager, G.W., Berghoff, A.S., Preusser, M., Bergen, E.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163163/
https://www.ncbi.nlm.nih.gov/pubmed/36989885
http://dx.doi.org/10.1016/j.esmoop.2023.101200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163163/
https://www.ncbi.nlm.nih.gov/pubmed/36989885
http://dx.doi.org/10.1016/j.esmoop.2023.101200

Ejemplares similares